Canada markets close in 4 hours 17 minutes

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.6700+0.0500 (+3.09%)
As of 11:39AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
0
0
0
37
869
Operating Expenses
Research Development
12,971
10,712
21,074
90,774
68,647
Selling General and Administrative
14,155
13,825
11,052
11,284
8,781
Total Operating Expenses
27,126
24,537
32,126
102,058
77,428
Operating Income or Loss
-27,126
-24,537
-32,126
-102,021
-76,559
Interest Expense
3,426
5,553
15,097
861
426
Total Other Income/Expenses Net
21,169
-60,769
-1,192
196
401
Income Before Tax
-9,383
-90,859
-51,263
-102,686
-76,584
Income Tax Expense
1,293
705
743
444
472
Income from Continuing Operations
-10,676
-91,564
-52,006
-103,130
-77,056
Net Income
-10,676
-91,564
-52,006
-103,130
-77,056
Net Income available to common shareholders
-10,676
-91,564
-52,006
-103,130
-77,056
Basic EPS
-
-8.40
-32.55
-106.50
-106.65
Diluted EPS
-
-8.40
-32.55
-106.50
-106.65
Basic Average Shares
-
10,891
1,601
967.869
582.273
Diluted Average Shares
-
10,891
1,601
967.869
582.273
EBITDA
-
-83,202
-36,005
-101,673
-76,022